1. Home
  2. USFD vs GMAB Comparison

USFD vs GMAB Comparison

Compare USFD & GMAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo US Foods Holding Corp.

USFD

US Foods Holding Corp.

HOLD

Current Price

$92.28

Market Cap

18.1B

ML Signal

HOLD

Logo Genmab A/S ADS

GMAB

Genmab A/S ADS

HOLD

Current Price

$25.30

Market Cap

16.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
USFD
GMAB
Founded
2007
1999
Country
United States
Denmark
Employees
N/A
3088
Industry
Food Distributors
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
18.1B
16.5B
IPO Year
2016
N/A

Fundamental Metrics

Financial Performance
Metric
USFD
GMAB
Price
$92.28
$25.30
Analyst Decision
Buy
Strong Buy
Analyst Count
11
8
Target Price
$103.64
$39.56
AVG Volume (30 Days)
2.5M
1.6M
Earning Date
05-07-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
45.54
N/A
EPS
0.52
N/A
Revenue
$39,424,000,000.00
N/A
Revenue This Year
$7.63
$17.85
Revenue Next Year
$3.92
$16.04
P/E Ratio
$179.80
$1.90
Revenue Growth
4.08
N/A
52 Week Low
$69.88
$20.23
52 Week High
$102.13
$35.43

Technical Indicators

Market Signals
Indicator
USFD
GMAB
Relative Strength Index (RSI) 63.70 47.79
Support Level $88.34 $23.62
Resistance Level $94.51 $27.37
Average True Range (ATR) 2.49 0.58
MACD 1.18 0.08
Stochastic Oscillator 77.83 74.73

Price Performance

Historical Comparison
USFD
GMAB

About USFD US Foods Holding Corp.

US Foods Holding Corp is a U.S. food service distributor that distributes food and nonfood products to the healthcare and hospitality industries, restaurants, education, government facilities, and grocers. It has various customer locations across the United States, with a vast network of distribution facilities, a fleet of trucks, and cash and carry locations offering food and non-food products, and a comprehensive suite of e-commerce, technology, and business solutions to its customers. The company operates in one business segment in which it markets, sells, and distributes fresh, frozen, and dry food and non-food products to foodservice customers throughout the U.S. The products offered are as snacks, beverages, fresh produce, sauces, condiments, canned/frozen fruits and others.

About GMAB Genmab A/S ADS

Genmab is a Copenhagen-based biotechnology company specializing in antibody therapeutics for the treatment of cancer. Genmab's proprietary antibody technologies are DuoBody, HexaBody, DuoHexaBody, and HexElect. Johnson & Johnson partnered with Genmab to create Darzalex, which is regarded as the standard of care for multiple myeloma and is Genmab's leading product. Genmab also has Tepezza for thyroid eye disease (partnered with Horizon), Kesimpta for relapsing multiple sclerosis (partnered with Novartis), Rybrevant (partnered with Johnson & Johnson) for non-small cell lung cancer (NSCLC), Tivdak (partnered with Seagen) for cervical cancer, and Epkinly (partnered with AbbVie) for diffuse large B-cell lymphoma. Genmab has several pipeline candidates targeting other oncologic indications.

Share on Social Networks: